Ideaya Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $7,000 | $0 |
Gross Profit | 6,357 | |||
EBITDA | -88,806 | -83,256 | -143,495 | -66,893 |
EBIT | -84,389 | -144,138 | -67,905 | |
Net Income | -77,491 | -71,405 | -130,312 | -51,821 |
Net Change In Cash | 0 | 0 | 7,000 | 0 |
Free Cash Flow | -63,137 | -61,672 | -122,757 | -49,691 |
Cash | 114,645 | 129,996 | 84,378 | 400,283 |
Basic Shares | 88,472 | 88,356 | 87,341 | 86,188 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $7,000 | $23,385 | $50,931 | $27,941 |
Gross Profit | 7,000 | 19,377 | 50,931 | 27,941 |
EBITDA | -326,975 | -130,421 | -60,401 | -48,543 |
EBIT | -134,429 | -62,502 | -50,268 | |
Net Income | -274,477 | -112,961 | -54,808 | -47,531 |
Net Change In Cash | 7,000 | 23,385 | 50,931 | 27,941 |
Cost of Revenue | -23,414 | 20,009 | ||
Free Cash Flow | -251,441 | -117,592 | -90,618 | -58,423 |
Cash | 84,378 | 157,018 | 68,632 | 92,046 |
Basic Shares | 81,678 | 57,519 | 41,444 | 35,252 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.88 |
2025-03-31 | -$1.49 |
2024-12-31 | -$1.49 |
